Jaguar Health Inc (NAS:JAGX) Stock News, Headlines & Updates
Jaguar Health Inc Stock News from GuruFocus
- 1
Jul 08, 2024
Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs)
ACCESSWIRE • 11:00am
Jun 26, 2024
Jaguar Health Regains Compliance with Nasdaq's Bid Price Requirement
ACCESSWIRE • 11:00am
Jun 22, 2024
Jaguar Health Reports Approval of All Proposals at June 2024 Annual Meeting of Stockholders
ACCESSWIRE • 7:00pm
Jun 12, 2024
Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer on or Before July 23, 2024
ACCESSWIRE • 11:00am
Jun 08, 2024
Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ACCESSWIRE • 11:00am
Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ACCESSWIRE • 7:00pm
May 29, 2024
Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia
ACCESSWIRE • 11:00am
May 28, 2024
Investigator-Initiated Trial of Jaguar Health's Crofelemer Yields Positive Results for Functional Diarrhea
ACCESSWIRE • 3:00pm
Investigator-Initiated Trial of Jaguar Health's Crofelemer Yields Positive Results for Functional Diarrhea
ACCESSWIRE • 11:00am
May 18, 2024
Jaguar Health, Inc. Announces Reverse Stock Split
ACCESSWIRE • 7:00pm
May 15, 2024
Jaguar Health Inc (JAGX) Q1 2024 Earnings Call Transcript Highlights: Strategic Expansions and Financial Improvements
GuruFocus Research • 1:02am
Q1 2024 Jaguar Health Inc Earnings Call Transcript
GuruFocus Research • 11:07pm
May 14, 2024
Jaguar Health Reports First Quarter 2024 Financial Results
ACCESSWIRE • 11:00am
May 13, 2024
REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates
ACCESSWIRE • 3:00pm
May 09, 2024
Jaguar Health Announces Submission of Clinical Trial Applications for Crofelemer for the Rare Disease Indications Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome (SBS) in Europe
ACCESSWIRE • 11:00am
May 08, 2024
Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates
ACCESSWIRE • 11:00am
Apr 29, 2024
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu Dhabi and Panel Discussion About Microvillus Inclusion Disease (MVID)
ACCESSWIRE • 11:00am
Apr 22, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news